Developing virus-based cancer vaccines with molecular enhancers

Project Code


Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Full Project Description

Please download the below document for a full project description and to see the full supervisory team.


Cancer immunotherapy has revolutionised the field of oncology. This project uses molecular enhancement of an established vaccine platform to develop cancer vaccines with increased potency. The project will harness the power of extracellular vesicles to augment vaccine-induced T cell immunity against cancer and oncogenic viruses, using interdisciplinary in vitro, ex vivo and in vivo (zebrafish, mice) methodologies and approaches.

Lead Supervisor

Dr Carly Bliss

Lead Supervisor Email

University Affiliation